Remove Heart Failure Remove Innovation Remove Patient Care
article thumbnail

Heart Rhythm Society’s HRX 2024 to Draw Cardiovascular Innovators to Atlanta

DAIC

The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept.

article thumbnail

Clinical Study Highlights Research on AI that Takes on Cardiopulmonary Killer

DAIC

Additionally, the algorithm demonstrated its ability to pinpoint specific, clinically relevant segments of heart sound recordings, offering a transparent and explainable AI approach that aligns with physicians diagnostic workflows. Our findings represent a significant advancement in clinical practice that can ultimately enhance patient care."

article thumbnail

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

DAIC

milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.

article thumbnail

Artificial Intelligence Speeds Up Heart Scans, Leading to Efficiency and Improving Outcomes

DAIC

Lead researcher Dr Pankaj Garg , of the University of East Anglia’s Norwich Medical School and a consultant cardiologist at the Norfolk and Norwich University Hospital, heads up a team of researchers who have pioneered innovative and revolutionary 4D MRI imaging technology.

Outcomes 122
article thumbnail

Cardiac Care AI Company, Anumana, Announces Receipt of ISO 13485 Certification

DAIC

Anumana’s software-as-a-medical device (SaMD) ECG-AITM solutions aim to detect hidden diseases using standard-of-care ECG readings, enabling clinicians to enhance and improve care with real-time AI insights. Food and Drug Administration ( FDA ) clearance in September 2023, and is currently under review in Europe.

article thumbnail

Reprieve Cardiovascular Looks to Transform ADHF Decongestion Management

CardiacWire

Reprieve Cardiovascular emerged this week , announcing a hefty $42M Series A round and an even bigger mission to “transform the standard of care” for patients with acute decompensated heart failure. The post Reprieve Cardiovascular Looks to Transform ADHF Decongestion Management appeared first on Cardiac Wire.

article thumbnail

American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24

DAIC

Here is an overview of sessions, events and meetings coordinated to help members in particular specialties, sections and areas of interest learn and engage with peers and expert cardiology professionals to advance their practice, patient care and careers. 24 Education Sessions Symposiums at ACC The “Symposiums at ACC.24”

Education 105